Evidence map›Paper›PMID 42400311›Full record

ArticleBiotechnology progress

Purification and concentration of model viruses using single-pass tangential flow filtration.

Luis Alberto Mejía-Manzano, Lynn Manchester, Grace Wallis, Kan Wang, Bruce P Lee, Michael Betenbaugh, Caryn L Heldt

Abstract read
In one paragraph

Article in Biotechnology progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis Alberto Mejía-ManzanoDepartment of Chemical Engineering, Michigan Technological University, Houghton, Michigan, USA.
Lynn ManchesterDepartment of Chemical Engineering, Michigan Technological University, Houghton, Michigan, USA.
Grace WallisDepartment of Chemical Engineering, Michigan Technological University, Houghton, Michigan, USA.
Kan WangDepartment of Biomedical Engineering, Michigan Technological University, Houghton, Michigan, USA.
Bruce P LeeDepartment of Biomedical Engineering, Michigan Technological University, Houghton, Michigan, USA.ORCID https://orcid.org/0000-0002-6529-0032
Michael BetenbaughDepartment of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-6336-4659
Caryn L HeldtDepartment of Chemical Engineering, Michigan Technological University, Houghton, Michigan, USA.ORCID https://orcid.org/0000-0002-0776-8763

Funding

FDA HHS R01 FD007461Office of Navel Research N00014-21-1U.S. Food and Drug Administration 1R01FD007461
6 · The paper itself

Abstract

The vaccine and viral vector industry is growing at an accelerated rate. To improve harvest and purification processes, the development of continuous membrane-based operations, such as normal flow filtration (NFF) and single pass tangential flow filtration (SPTFF) for concentration were explored. This work was conducted using two model viruses, non-enveloped porcine parvovirus (PPV) and enveloped Suid herpesvirus (SuHV). The viruses are in the same family as the gene therapy vectors adeno associated virus and herpes simplex virus, respectively. SPTFF design started with batch TFF for membrane selection. Hollow fiber membranes with a 100 and 300 kDa molecular weight cut off were defined for PPV and SuHV SPTFF operations, respectively. The SPTFF runs for PPV did not provide any concentration of the virus and low protein and DNA removal, unlike batch TFF. Two hollow fiber membranes run at 10 mL/min and 2 psi were the best condition for SuHV concentration, with approximately 100-fold titer concentration and protein and DNA removal of 37% ± 5% and 32% ± 8%, respectively. This concentration was superior to the batch TFF and indicated a strong dependence on flow rate and transmembrane pressure. For NFF, filters selection and performance tests were carried out for NFF of PPV and SuHV, as well as cleaning protocols for hollow fiber membranes. The ultimate goal is to integrate this work into the continuous purification of viral vectors produced in mammalian cell cultures to reduce costs and increase throughput.

Indexed as

FiltrationHerpesvirus 1, SuidParvovirus, PorcineAnimalsMembranes, ArtificialSwineMembranes, Artificialbioprocessingcontinuous manufacturingmembrane filtrationvaccineviral vectorvirus

Identifiers

PMID42400311
PMCPMC13636614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.